copegus 200 mg filmovertrukne tabletter
roche a/s - ribavirin - filmovertrukne tabletter - 200 mg
copegus 400 mg filmovertrukne tabletter
roche a/s - ribavirin - filmovertrukne tabletter - 400 mg
copegus 200 mg filmovertrukne tabletter
orifarm a/s - ribavirin - filmovertrukne tabletter - 200 mg
copegus 400 mg filmovertrukne tabletter
orifarm a/s - ribavirin - filmovertrukne tabletter - 400 mg
lescol 40 mg kapsler, hårde
novartis healthcare a/s - fluvastatinnatrium - kapsler, hårde - 40 mg
avipro ae oral suspension til brug i drikkevand
lohmann animal health gmbh - aviær encephalomyelitis virus, stamme 1143 calnek (levende, svækket) - oral suspension til brug i drikkevand - fjerkræ
avipro gumboro vac pulver til opløsning i drikkevand
lohmann animal health gmbh - infektiøs bursitis virus, stamme cu 1, frysetørret (levende) - pulver til opløsning i drikkevand - fjerkræ
hipragumboro cw lyofilisat til anvendelse i drikkevand
laboratorios hipra s.a. - infektiøs bursitis virus, stamme ch/80, frysetørret (levende) - lyofilisat til anvendelse i drikkevand - fjerkræ
carvykti
janssen-cilag international nv - ciltacabtagene autoleucel - multipelt myelom - carvykti is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.
cdq st brusetablet
du pont danmark aps - tribenuron-methyl, tribenuron, metsulfuron-methyl, metsulfuron - brusetablet - 333,33 g/kg tribenuron-methyl; (~ 322 g/kg tribenuron; 166,67 g/kg metsulfuron-methyl; (~ 161 g/kg metsulfuron